ZYLiQ Expands Regulatory Writing Automation with Launch of Version 4.0 and New Regulatory Modules

Version 4.0 introduces a suite of enhancements for CSR automation, including: Version 4.0 introduces a suite of enhancements for CSR automation, including: In addition,new modules debut in ZYLiQ 4.0  for other regulatory documents using GenAI: To validate its claims, ZYLiQ offers prospective customers afree two-week pilot, enabling side-by-side comparisons of legacy processes versus ZYLiQ's accelerated automation. "Our focus on regulatory document automation—rather than diluting...
Comunicato Precedente

next
Comunicato Successivo

next

Version 4.0 introduces a suite of enhancements for CSR automation, including:

In addition, new modules debut in ZYLiQ 4.0 for other regulatory documents using GenAI:

To validate its claims, ZYLiQ offers prospective customers a free two-week pilot, enabling side-by-side comparisons of legacy processes versus ZYLiQ's accelerated automation.

"Our focus on regulatory document automation—rather than diluting efforts across many document types—has allowed us to build an exceptionally effective solution," said Farha Feroze, ZYLiQ's Inventor and Director of Product Management. "With Version 4.0, we are excited to expand beyond CSR and deliver the same level of innovation to other regulatory documents. I am proud of my team's effort towards adoption of advanced technologies and better use cases."

About ZYLiQ

ZYLiQ Expands Regulatory Writing Automation with Launch of Version 4.0 and New Regulatory Modules

Built on three decades of experience at CRO Symbiance, ZYLiQ combines deep domain expertise in Life Sciences with proven AI/ML innovation and In-depth understanding of customer's pain points.

Book a demo 

Contact us:  [email protected] || www.zyliq.ai || +1 949-878-2121

Logo - https://mma.prnewswire.com/media/2800960/ZYLIQ_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/zyliq-expands-regulatory-writing-automation-with-launch-of-version-4-0-and-new-regulatory-modules-302590031.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;